Attention Deficit Hyperactivity Disorder (ADHD)
Mental Health
Attention Deficit Hyperactivity Disorder (ADHD) is treated with 2 medications in our database, including Focalin XR, QELBREE. 2 of these have manufacturer assistance programs available to help reduce out-of-pocket costs. Medications are manufactured by Novartis, Supernus. Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Attention Deficit Hyperactivity Disorder (ADHD) treatment below.
What help exists for Attention Deficit Hyperactivity Disorder (ADHD)
2
drugs indexed
2
with copay cards
2
with patient assistance
0
open travel grants
Every item below links to the manufacturer's or charity's own portal. RxCopays does not take referral fees.
Drugs used to treat Attention Deficit Hyperactivity Disorder (ADHD)
2 totalFocalin XR
dexmethylphenidate hydrochloride
ππQELBREE
viloxazine hydrochloride Β· Supernus
ππ
π = copay card Β· π = patient assistance program
Prior authorization patterns for Attention Deficit Hyperactivity Disorder (ADHD) drugs
Aggregated from CMS SPUF + commercial PBM formularies. Specific rules vary by plan; confirm with your insurer.
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |